Patricia B. Petray

766 total citations
28 papers, 640 citations indexed

About

Patricia B. Petray is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Parasitology. According to data from OpenAlex, Patricia B. Petray has authored 28 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 19 papers in Public Health, Environmental and Occupational Health and 10 papers in Parasitology. Recurrent topics in Patricia B. Petray's work include Trypanosoma species research and implications (24 papers), Research on Leishmaniasis Studies (19 papers) and Parasites and Host Interactions (5 papers). Patricia B. Petray is often cited by papers focused on Trypanosoma species research and implications (24 papers), Research on Leishmaniasis Studies (19 papers) and Parasites and Host Interactions (5 papers). Patricia B. Petray collaborates with scholars based in Argentina, Sweden and United States. Patricia B. Petray's co-authors include Ricardo S. Corral, Martı́n E. Rottenberg, Saúl Grinstein, Anders Örn, Eder Lilia Romero, María José Morilla, Fernanda M. Frank, Emilio L. Malchiodi, Esmeralda Castaños‐Vélez and Miriam Postan and has published in prestigious journals such as PLoS ONE, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

Patricia B. Petray

28 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patricia B. Petray Argentina 15 443 345 143 139 115 28 640
A. M. RUIZ Argentina 13 611 1.4× 413 1.2× 131 0.9× 96 0.7× 140 1.2× 21 714
Herbert A. Avila United States 8 646 1.5× 523 1.5× 227 1.6× 68 0.5× 255 2.2× 8 953
Pius N. Nde United States 15 338 0.8× 247 0.7× 63 0.4× 117 0.8× 218 1.9× 36 618
Jacqueline Búa Argentina 18 765 1.7× 556 1.6× 201 1.4× 75 0.5× 268 2.3× 48 915
Catalina D. Alba Soto Argentina 18 328 0.7× 372 1.1× 185 1.3× 471 3.4× 121 1.1× 35 935
Ises de Almeida Abrahamsohn Brazil 9 290 0.7× 292 0.8× 104 0.7× 104 0.7× 110 1.0× 10 439
Mireille Hontebeyrie France 13 316 0.7× 221 0.6× 80 0.6× 43 0.3× 70 0.6× 19 418
Paulo C. Cotrim Brazil 15 354 0.8× 418 1.2× 97 0.7× 60 0.4× 107 0.9× 32 567
Stefan Kunz Switzerland 18 569 1.3× 298 0.9× 57 0.4× 33 0.2× 435 3.8× 28 896
Márcia Regina Machado dos Santos Brazil 15 393 0.9× 286 0.8× 81 0.6× 39 0.3× 161 1.4× 28 518

Countries citing papers authored by Patricia B. Petray

Since Specialization
Citations

This map shows the geographic impact of Patricia B. Petray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia B. Petray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia B. Petray more than expected).

Fields of papers citing papers by Patricia B. Petray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia B. Petray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia B. Petray. The network helps show where Patricia B. Petray may publish in the future.

Co-authorship network of co-authors of Patricia B. Petray

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia B. Petray. A scholar is included among the top collaborators of Patricia B. Petray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia B. Petray. Patricia B. Petray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frank, Fernanda M., David H. Wagner, Miriam Postan, & Patricia B. Petray. (2023). Importance of CD40/CD40L dyad in the course of infection with Trypanosoma cruzi: Impact of its inhibition. Microbial Pathogenesis. 183. 106327–106327. 1 indexed citations
2.
Petray, Patricia B., et al.. (2020). Circulating T Follicular Helper Cell Abnormalities Associated to Different Clinical Forms of Chronic Chagas Disease. Frontiers in Cellular and Infection Microbiology. 10. 126–126. 8 indexed citations
3.
Frank, Fernanda M., et al.. (2020). Imiquimod-loaded nanoarchaeosomes as a promising immunotherapy against Trypanosoma cruzi infection. Colloids and Surfaces B Biointerfaces. 189. 110850–110850. 9 indexed citations
4.
Leroux, Alejandro E., et al.. (2017). Molecular and functional characterization of two malic enzymes from Leishmania parasites. Molecular and Biochemical Parasitology. 219. 67–76. 6 indexed citations
5.
Petray, Patricia B., et al.. (2017). Germacranolide-type sesquiterpene lactones from Smallanthus sonchifolius with promising activity against Leishmania mexicana and Trypanosoma cruzi. Parasites & Vectors. 10(1). 567–567. 17 indexed citations
7.
Ayala, Mariela A. Moreno, et al.. (2015). Trypanosoma cruzi infection induces the expression of CD40 in murine cardiomyocytes favoring CD40 ligation-dependent production of cardiopathogenic IL-6. Parasitology Research. 115(2). 779–785. 6 indexed citations
8.
Romero, Eder Lilia, Ana Paula Perez, Priscila Schilrreff, et al.. (2014). Enhanced photodynamic leishmanicidal activity of hydrophobic zinc phthalocyanine within archaeolipids containing liposomes. International Journal of Nanomedicine. 9. 3335–3335. 21 indexed citations
9.
Corral, Ricardo S., et al.. (2013). Archaeosomes display immunoadjuvant potential for a vaccine against Chagas disease. Human Vaccines & Immunotherapeutics. 9(2). 409–412. 18 indexed citations
11.
Gulin, Julián Ernesto Nicolás, et al.. (2012). Efficacy of voriconazole in a murine model of acute Trypanosoma cruzi infection. Journal of Antimicrobial Chemotherapy. 68(4). 888–894. 17 indexed citations
12.
Postan, Miriam, et al.. (2011). Immunomodulatory and anti-fibrotic effects of ganglioside therapy on the cardiac chronic form of experimental Trypanosoma cruzi infection. International Immunopharmacology. 11(8). 1024–1031. 8 indexed citations
14.
Morilla, María José, Jorge Montanari, Fernanda M. Frank, et al.. (2005). Etanidazole in pH-sensitive liposomes: Design, characterization and in vitro/in vivo anti-Trypanosoma cruzi activity. Journal of Controlled Release. 103(3). 599–607. 33 indexed citations
16.
Petray, Patricia B., Ricardo S. Corral, Patricia Cabeza Meckert, & Rubén P. Laguens. (2002). Role of macrophage inflammatory protein-1α (MIP-1α) in macrophage homing in the spleen and heart pathology during experimental infection with Trypanosoma cruzi. Acta Tropica. 83(3). 205–211. 18 indexed citations
17.
Corral, Ricardo S. & Patricia B. Petray. (2000). CpG DNA as a Th1-promoting adjuvant in immunization against Trypanosoma cruzi. Vaccine. 19(2-3). 234–242. 50 indexed citations
18.
Altcheh, Jaime, Ricardo S. Corral, S Grinstein, et al.. (1994). Detection of urine antigens in chronic chagasic patients. Memórias do Instituto Oswaldo Cruz. 89. 163. 1 indexed citations
19.
Petray, Patricia B., Martı́n E. Rottenberg, Saúl Grinstein, & Anders Örn. (1994). Release of nitric oxide during the experimental infection with Trypanosoma cruzi. Parasite Immunology. 16(4). 193–199. 57 indexed citations
20.
Petray, Patricia B., et al.. (1990). EFFECT OF MONOCLONAL ANTIBODY AGAINST INTERFERON GAMMA ON TRYPANOSOMA CRUZI INFECTION. Medical science research. 18(24). 953–954. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026